文献速递血栓与止血贫血与红细胞疾病

儿童ITP二线TPO-RA治疗期间COVID-19感染相关的一过性血小板计数升高

Transient increase in platelet counts associated with COVID-19 infection during TPO-RA as the second-line treatment in children with ITP.
PubMed 文献 · Br J Haematol · 2023-08-23

单中心观察性队列研究纳入67例接受TPO-RA二线治疗的儿童慢性免疫性血小板减少症(CITP)患者,63例对TPO-RA有应答者在2022年12月COVID-19感染后出现一过性血小板升高,峰值289(88,1974)×10^9/L,100%(63/63)在感染后第25(14,41)天降至基线。

要点

  • 对TPO-RA有应答的CITP患儿在COVID-19感染后出现一过性血小板升高,峰值289(88,1974)×10^9/L。
  • 血小板开始升高时间为感染后第3(2,7)天,达峰时间为第14(7,19)天。
  • 100%(63/63)患儿血小板在感染后第25(14,41)天降至基线。

核心结论

  • 对TPO-RA有应答的CITP患儿在COVID-19感染后出现一过性血小板计数升高现象。

研究设计与样本

  • 单中心观察性队列研究,2022年12月初至2023年2月底入组67例(男34例、女33例)接受TPO-RA单药二线治疗的CITP患儿,年龄8.10(2.15,15.70)岁,均于2022年12月感染COVID-19。

主要发现

  • 63例对TPO-RA有应答的患者在COVID-19感染后出现一过性血小板升高,开始升高时间为感染后第3(2,7)天,达峰时间为第14(7,19)天,峰值血小板计数为289(88,1974)×10^9/L。
  • 从COVID-19感染起至少观察2个月,100%(63/63)患者血小板在感染后第25(14,41)天降至基线。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The thrombopoietin receptor agonists (TPO-RA) were recommended for primary immune thrombocytopenia (ITP) during the pandemic of COVID-19. However, the incidence of thrombocytosis and thrombosis was sporadically reported in the chronic immune thrombocytopenia (CITP) patients receiving TPO-RA during the COVID-19 infection. With the local prevalence of COVID-19 in December 2022 in the Beijing area, we got more powerful evidence about the change in platelet (Plt) counts associated with COVID-19 infection. A single-centre observational cohort study was performed from the beginning of December 2022 to the end of February 2023 to enrol CITP children treated with TPO-RA alone as the second-line treatment and suffering from the COVID-19 infection in December 2022. The Plt counts before, during and after COVID-19 infection were collected. In total, 67 (34 males and 33 females) patients with 8.10 (2.15, 15.70) years of age were enrolled. Sixty-three patients who had responded to the TPO-RA showed a transient increase in Plt counts after the infection of COVID-19. The time of starting to increase was on Day 3 (2, 7), and to the peak level on Day 14 (7, 19) of infection with the peak Plt count was 289 (88, 1974) × 109 /L. With at least 2 months observation period from COVID-19 infection, the Plt counts of 100% (63/63) patients declined to the baseline on Day 25 (14, 41). The phenomenon of transient increase in Plt counts has been shown in the CITP children who responded to TPO-RA when suffering from COVID-19 infection.

来源:Br J Haematol,查看原文。版权归原作者所有。

引用

  1. Wang Z, Cheng X, Wang N, et al. Transient increase in platelet counts associated with COVID-19 infection during TPO-RA as the second-line treatment in children with ITP. Br J Haematol. 2023. PMID: 37609794. doi:10.1111/bjh.19040

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。